Literature DB >> 28218347

Breast cancer: early diagnosis and effective treatment by drug delivery tracing.

Mahdiyeh Shamsi1, Jalil Pirayesh Islamian.   

Abstract

Breast cancer is the most frequent cancer in women and it is the main reason of cancer-related deaths of women worldwide. Different types of breast cancer diagnostic examinations are also available, such as mammography, MRI, biopsy, ultrasound and molecular imaging. Radionuclide-based imaging methods including SPECT and PET are useful in early diagnosis and treatment of the cancer. The radiolabeling of chemo drugs with nanoparticles should be recommended from the standpoint of an early diagnosis and effective treatment of breast cancer.

Entities:  

Keywords:  breast cancer; chemotherapy; diagnosis; radiotracer

Mesh：

Substances：

Year:  2017        PMID： 28218347     DOI： 10.5603/NMR.2017.0002

Source DB:  PubMed          Journal:  Nucl Med Rev Cent East Eur        ISSN： 1506-9680


  12 in total

1.  LncRNA MIR4435-2HG promotes proliferation, migration, invasion and epithelial mesenchymal transition via targeting miR-22-3p/TMEM9B in breast cancer.

Authors:  Jing Ke; Quhui Wang; Wei Zhang; Sujie Ni; Haijun Mei
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

2.  Transcription factor KLF16 activates MAGT1 to regulate the tumorigenesis and progression of breast cancer.

Authors:  Lin Li; Xi Zhang; Yuqi Li; Bo Xiao; Sibiao Pei; Hangyu Jiang; Xiaofen Zhang
Journal:  Int J Mol Med       Date:  2022-07-07       Impact factor: 5.314

Review 3.  Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer.

Authors:  Jörgen Elgqvist
Journal:  Int J Mol Sci       Date:  2017-05-20       Impact factor: 5.923

4.  Paclitaxel suppresses proliferation and induces apoptosis through regulation of ROS and the AKT/MAPK signaling pathway in canine mammary gland tumor cells.

Authors:  Xiaoli Ren; Bingbing Zhao; Hongjian Chang; Min Xiao; Yuhong Wu; Yun Liu
Journal:  Mol Med Rep       Date:  2018-04-11       Impact factor: 2.952

5.  Comparative Analysis of Vaginal Microbiota in Women with Breast Cancer in Kazakhstan.

Authors:  Farida K Balmaganbetova; Ainur Amanzholkyzy; Roza E Nurgaliyeva; Aiman T Kaldybayeva; Azhar N Zhexenova
Journal:  Asian Pac J Cancer Prev       Date:  2021-04-01

6.  "High-Risk Breast Cancer Screening in BRCA1/2 Carriers Leads to Early Detection and Improved Survival After a Breast Cancer Diagnosis".

Authors:  Shay Shraga; Albert Grinshpun; Aviad Zick; Luna Kadouri; Yogev Cohen; Ofra Maimon; Yael Adler-Levy; Galina Zeltzer; Avital Granit; Bella Maly; Einat Carmon; Vardiella Meiner; Tamar Sella; Tamar Hamburger; Tamar Peretz
Journal:  Front Oncol       Date:  2021-09-02       Impact factor: 6.244

Review 7.  Role of circulating tumor DNA and circulating tumor cells in breast cancer: History and updates.

Authors:  Julien Chedid; Sabine Allam; Nathalie Chamseddine; Maroun Bou Zerdan; Clara El Nakib; Hazem I Assi
Journal:  SAGE Open Med       Date:  2022-02-23

8.  Evaluation of Fructosamine 3-kinase and Glyoxalase 1 activity in normal and breast cancer tissues.

Authors:  Tooba Yousefi; Abdol Rahim Gholizadeh Pasha; Ghodsieh Kamrani; Ailin Ebrahimzadeh; Ali Zahedian; Karimollah Hajian-Tilaki; Mohammad Aghajani; Durdi Qujeq
Journal:  Biomedicine (Taipei)       Date:  2021-09-01

9.  Actin-binding Rho activating C-terminal like (ABRACL) transcriptionally regulated by MYB proto-oncogene like 2 (MYBL2) promotes the proliferation, invasion, migration and epithelial-mesenchymal transition of breast cancer cells.

Authors:  Jie Li; Hui Chen
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

Review 10.  Alternative Splicing in Breast Cancer and the Potential Development of Therapeutic Tools.

Authors:  Nancy Martínez-Montiel; Maricruz Anaya-Ruiz; Martín Pérez-Santos; Rebeca D Martínez-Contreras
Journal:  Genes (Basel)       Date:  2017-10-05       Impact factor: 4.096
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.